Vaccine efficacy elicited with heterologous DNA-VLP prime-boost strategy in mice following 1000 MLD<sub>50</sub> of homologous (A/Shenzhen/406H/06, clade 2.3.4) at 60 days post boost.
- Heng Ding (354199)
- Cheguo Tsai (354200)
- Ramona Alikiiteaga Gutiérrez (193968)
- Fan Zhou (196667)
- Philippe Buchy (106901)
- Vincent Deubel (204926)
- Paul Zhou (354201)
Publication date
February 2013
DOIAbstract
<p>A) Percentage of original body weight in individual mice after the 1,000 MLD<sub>50</sub> of homologous H5N1 virus challenge. Black color: PBS control group; red color: heterologous DNA-VLP prime-boost group. B) Survival rates after the 1,000 MLD<sub>50</sub> of homologous H5N1 virus challenge. Survival rate was calculated based on percent survival within each experimental group (n = 6 mice per experimental group).</p
Add to ORKG